Obesity Management Training for Independent Prescribers and Healthcare Professionals

Evidence-based obesity management, lifestyle medicine and pharmacological treatment training — including GLP-1 prescribing, Mounjaro and Wegovy — for independent prescribers in private practice.

Join Membership Enquire Now

Obesity Management Training

Evidence-Based Obesity Management for Independent Prescribers

Obesity is one of the most significant and growing areas of independent healthcare practice in the UK. Safe, effective obesity management requires a thorough understanding of the pathophysiology of obesity, evidence-based assessment frameworks, lifestyle and behavioural interventions, and the safe prescribing of pharmacological treatments including GLP-1 receptor agonists.

Our obesity management training is developed by experienced clinicians and is aligned to the latest NICE guidance, NHS England frameworks and UK regulatory requirements. It is available as part of The Compliance Clinic Membership, alongside clinical governance resources, prescribing guidance and clinical supervision.

What the Training Covers

Pathophysiology of Obesity

Understanding the biological, psychological and social drivers of obesity and their implications for treatment.

Assessment Frameworks

Evidence-based obesity assessment including BMI, waist circumference, metabolic risk and comorbidity screening.

Lifestyle Medicine

Dietary, physical activity and behavioural interventions for sustainable weight management.

GLP-1 Prescribing

Safe prescribing of GLP-1 receptor agonists including Mounjaro, Wegovy and Saxenda with governance frameworks.

Patient Selection & Monitoring

Patient eligibility criteria, monitoring protocols and safe prescribing decision-making frameworks.

Prescribing Governance

Clinical governance requirements for weight management services including SOPs, consent and audit tools.

GLP-1 Prescribing and Weight Management Medicines

Our obesity management training includes comprehensive guidance on the prescribing of GLP-1 receptor agonists — the most significant pharmacological development in weight management in a generation. This includes Mounjaro (tirzepatide), Wegovy (semaglutide), Saxenda (liraglutide) and other agents, covering patient selection, dosing, monitoring, side effect management, prescribing governance and clinical audit. Dedicated GLP-1 prescribing training is also available as a standalone course within the membership.

Frequently Asked Questions

What does the obesity management training cover?

Pathophysiology of obesity, evidence-based assessment, lifestyle medicine, behavioural interventions, pharmacological treatment including GLP-1 receptor agonists, patient selection and monitoring, prescribing governance and clinical audit tools.

Is this training suitable for nurse prescribers?

Yes. Our training is specifically designed for independent nurse prescribers, doctors and pharmacist independent prescribers working in private practice.

Does the training include GLP-1 prescribing guidance?

Yes. The training includes comprehensive GLP-1 prescribing guidance covering Mounjaro, Wegovy, Saxenda and other GLP-1 receptor agonists. Dedicated GLP-1 prescribing training is also available as a standalone course.

How do I access obesity management training?

Available as part of The Compliance Clinic Membership, which provides access to all specialist clinical courses, governance resources, prescribing guidance and clinical supervision.

Access Obesity Management Training

Join The Compliance Clinic Membership for expert-led obesity management training, GLP-1 prescribing guidance, governance resources and clinical supervision.

Join MembershipEnquire Now